Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Goodwill (2020 - 2025)

Pulse Biosciences has reported Goodwill over the past 6 years, most recently at $2.8 million for Q3 2025.

  • Quarterly results put Goodwill at $2.8 million for Q3 2025, changed 0.0% from a year ago — trailing twelve months through Sep 2025 was $2.8 million (changed 0.0% YoY), and the annual figure for FY2024 was $2.8 million, changed 0.0%.
  • Goodwill for Q3 2025 was $2.8 million at Pulse Biosciences, roughly flat from $2.8 million in the prior quarter.
  • Over the last five years, Goodwill for PLSE hit a ceiling of $2.8 million in Q1 2021 and a floor of $2.8 million in Q1 2021.
  • Median Goodwill over the past 5 years was $2.8 million (2021), compared with a mean of $2.8 million.
  • Peak annual rise in Goodwill hit 0.0% in 2021, while the deepest fall reached 0.0% in 2021.
  • Pulse Biosciences' Goodwill stood at $2.8 million in 2021, then changed by 0.0% to $2.8 million in 2022, then changed by 0.0% to $2.8 million in 2023, then changed by 0.0% to $2.8 million in 2024, then changed by 0.0% to $2.8 million in 2025.
  • The last three reported values for Goodwill were $2.8 million (Q3 2025), $2.8 million (Q2 2025), and $2.8 million (Q1 2025) per Business Quant data.